The burden of inflammatory bowel disease (IBD) in older adults (ie, aged over 60 years old)
is increasing due to a combination of an ageing population with compounding prevalence of …

The incidence and prevalence of inflammatory bowel disease (IBD) is rising in the elderly
population. Compared with patients with onset during their younger years, patients with …

Short-and long-term treatment targets in inflammatory bowel diseases (IBDs) evolved during
the last decade, shifting from symptom control to endoscopic healing and patient-centered …

Background Several studies have shown that neurodegenerative diseases (eg, Parkinson's
disease [PD] and Alzheimer's disease [AD]) are associated with inflammatory bowel disease …

Abstract The burden of Inflammatory Bowel Disease (IBD) is increasing worldwide, with a
particular increase in the prevalence in the elderly population, due to the ageing of young …

Abstract Background and Aims Tofacitinib (TFB) appears to be effective in the treatment of
ulcerative colitis (UC); however, available real-world studies are limited by cohort size. TFB …

Background This study aims to examine the prospective association of inflammatory bowel
disease (IBD) with long-term risk of overall, site-specific cancer and cancer-specific mortality …

Background Patients suffering from inflammatory bowel disease (IBD) have an increased
risk of cancer. However, the risk of malignancy in patients with elderly-onset IBD (≥ 60 …

Inflammatory bowel diseases (IBD), including Crohn's disease (CD) and ulcerative colitis
(UC), are lifelong diseases characterized by chronic inflammation of the gastrointestinal tract …

Approximately one out of every 88 seniors has inflammatory bowel disease (IBD), and this is
expected to increase in the future. They are more likely to have left-sided disease in …